To further corroborate this observation, we inactivated the ADH5 gene in the non-blood derived human colorectal carcinoma cell line HCT116 by CRISPR/Cas9 (Supplementary Fig. 1b). This evidence concerns the gene ADH5 and colorectal carcinoma.